Konstantin Konstantinov | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Konstantin Konstantinov
Researcher Konstantin Konstantinov
Affiliation University of New Mexico
Country United States
Scopus ID 55808069944
Documents 38
Citations
2,384
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards

Konstantin Konstantinov
University of New Mexico

Konstantin Konstantinov, affiliated with the University of New Mexico, is a researcher in Clinical Medicine whose scholarly work contributes to advancing evidence-based biomedical research. His publications indexed in Scopus demonstrate sustained engagement with clinically relevant investigations, interdisciplinary collaboration, and scientific dissemination. This recognition article summarizes his research profile, scholarly contributions, publication themes, research impact, and suitability for the Health Scientists Awards, based on publicly available academic records and recognized scholarly databases.[1]

Abstract

Konstantin Konstantinov has established an academic profile within Clinical Medicine through scholarly publications emphasizing translational biomedical research, disease mechanisms, diagnostic innovation, clinical applications, and collaborative investigation. His work reflects sustained participation in internationally indexed research while contributing to evidence-based healthcare knowledge. Publications demonstrate methodological rigor, scientific relevance, and interdisciplinary cooperation across medical sciences. Indexed visibility through Scopus and ORCID supports transparent scholarly communication and research accessibility. Collectively, these achievements indicate meaningful engagement with contemporary clinical research and provide a credible foundation for recognition through international academic awards dedicated to advancing health sciences and biomedical innovation.[1][2]

Keywords

Clinical Medicine, Biomedical Research, Translational Medicine, Disease Mechanisms, Biomarkers, Immunology, Molecular Medicine, Diagnostics, Therapeutics, Patient Care, Precision Medicine, Clinical Investigation, Medical Innovation, Healthcare Research, Evidence-Based Medicine.

Introduction

Konstantin Konstantinov conducts research emphasizing clinically relevant biomedical investigations that integrate laboratory findings with healthcare applications. His scholarly activities contribute to understanding disease processes, improving diagnostic strategies, and strengthening translational medicine. Indexed publications demonstrate consistent scientific engagement while supporting evidence-driven clinical practice across multidisciplinary healthcare environments.[1]

Research Profile

Konstantin Konstantinov maintains a recognized research profile through Scopus and ORCID, reflecting internationally indexed scholarly contributions. His affiliation with the University of New Mexico supports collaborative medical research, interdisciplinary partnerships, and dissemination of findings within respected scientific journals addressing clinical medicine and biomedical innovation.[2]

Research Contributions

Konstantin Konstantinov contributes to biomedical knowledge through investigations addressing clinical challenges, disease biology, and translational healthcare solutions. His research emphasizes scientific reliability, collaborative methodologies, and practical medical relevance, helping strengthen understanding of therapeutic development while supporting continued advancement of evidence-based clinical medicine internationally.[3]

Publications

Konstantin Konstantinov has authored and co-authored peer-reviewed publications indexed within Scopus, reflecting sustained participation in internationally recognized biomedical literature. His publication portfolio demonstrates scientific consistency, collaborative authorship, and continuing contributions to clinical medicine through research addressing contemporary healthcare questions and translational scientific applications.[1]

Research Impact

Konstantin Konstantinov demonstrates measurable scholarly visibility through internationally indexed publications, citation tracking, and persistent researcher identifiers. His scientific contributions encourage collaboration, knowledge dissemination, and continuing academic influence within clinical medicine while supporting reproducible research standards and responsible advancement of healthcare-related scientific investigation.[2]

Award Suitability

Konstantin Konstantinov demonstrates characteristics aligned with the objectives of the Health Scientists Awards through sustained scholarly productivity, internationally indexed research, interdisciplinary collaboration, and clinically relevant scientific contributions. His academic profile supports consideration for recognition based upon documented research quality, visibility, and professional scientific engagement.[4]

Conclusion

Konstantin Konstantinov represents an active clinical medicine researcher whose internationally indexed publications, institutional affiliation, and commitment to evidence-based biomedical investigation demonstrate meaningful scientific engagement. His documented academic profile provides an appropriate basis for professional recognition within international research award programs supporting healthcare innovation and scientific excellence.[1]

External Links

References

    1. Elsevier. (n.d.). Scopus Author Details: Konstantin Konstantinov, Author ID 55808069944. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55808069944
    2. Konstantinov, K. N., Roldan, C. A., & Konstantinov, N. K. (n.d.). Sclerodactyly, tongue telangiectasias, premature severe aortic stenosis, and RNA polymerase III autoantibodies in a patient with syncope.
      https://pubmed.ncbi.nlm.nih.gov/37979901/

    3. Kumar, V., de Saint-Aubain, C. J., & Konstantinov, K. N. (n.d.). A diagnostic odyssey: Mevalonate kinase deficiency revealed by genetic testing in adulthood.

      https://doi.org/10.3390/genes17040439

    4. Health Scientists Awards. (n.d.). Official Awards Website.
      https://healthscientists.org/

Diana Hristova | Clinical Medicine | Best Medical Scientist Award

Published on by Health Scientists

Best Medical Scientist Award

Diana Hristova
Aleksandrovska University Hospital
Diana Hristova
Affiliation Aleksandrovska University Hospital
Country Bulgaria
Scopus ID 57450761900
Documents 12
Citations 55
h-index 3
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-9710-1312

The Best Medical Scientist Award recognizes researchers whose scholarly activities contribute to the advancement of medical science and patient-centered healthcare. Diana Hristova of Aleksandrovska University Hospital has developed a research profile within clinical medicine, contributing peer-reviewed publications and scholarly outputs that support evidence-based healthcare practices. Her academic activities, publication record, and participation in contemporary medical research demonstrate continued engagement with clinical investigation and scientific dissemination.[1]

Abstract

Diana Hristova is a clinical medicine researcher affiliated with Aleksandrovska University Hospital in Bulgaria. Her scholarly work focuses on medical research, patient care improvement, and evidence-based clinical practice. Through peer-reviewed publications and scientific collaboration, she has contributed to the understanding of healthcare challenges and clinical outcomes. Her research activities support the translation of scientific knowledge into practical healthcare applications. With documented publications, citations, and academic engagement, her profile reflects sustained participation in the advancement of medical science and clinical investigation while contributing to ongoing developments within contemporary healthcare research environments.[1]

Keywords

Clinical Medicine, Healthcare Research, Evidence-Based Medicine, Medical Science, Patient Care, Clinical Investigation, Medical Publications, Translational Research, Hospital Research, Health Outcomes

Introduction

Clinical medicine relies on rigorous research to improve patient outcomes and healthcare quality. Diana Hristova contributes to this objective through scholarly activities at Aleksandrovska University Hospital. Her research engagement supports scientific inquiry, knowledge dissemination, and evidence-based approaches that strengthen contemporary medical practice and healthcare decision-making processes.[1]

Research Profile

Diana Hristova maintains an active research profile within clinical medicine, supported by indexed publications and measurable scholarly impact. Her academic record demonstrates participation in peer-reviewed research, scientific communication, and collaborative medical investigations that contribute to the broader understanding of clinical challenges and healthcare improvement initiatives.[1]

Research Contributions

Her contributions involve clinical research activities that support evidence generation, patient-centered healthcare, and medical knowledge development. Through published studies and professional collaboration, she has participated in advancing scientific understanding relevant to healthcare practice, clinical assessment, and improved treatment strategies within medical environments.[2]

Publications

The researcher has authored and co-authored multiple scholarly publications indexed within recognized academic databases. These publications contribute to clinical medicine literature and reflect ongoing engagement with scientific research, peer review standards, and the dissemination of findings relevant to healthcare professionals and researchers.[1]

Research Impact

Research impact is reflected through citations, publication visibility, and academic engagement. Diana Hristova’s scholarly outputs contribute to knowledge exchange within clinical medicine. Her research record demonstrates recognized academic influence and supports the continued development of evidence-based healthcare practices across relevant medical disciplines.[1]

Award Suitability

The Best Medical Scientist Award emphasizes scientific contribution, research quality, and healthcare relevance. Diana Hristova’s publication record, documented citations, clinical research involvement, and commitment to evidence-based medicine align with these evaluation principles, making her profile suitable for consideration within medical science recognition programs.[1]

Conclusion

Diana Hristova demonstrates a sustained commitment to clinical medicine research through scholarly publication, academic collaboration, and healthcare-focused investigation. Her research profile reflects meaningful participation in scientific advancement and supports the objectives of medical innovation, evidence generation, and improved patient care outcomes.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Diana Hristova, Author ID 57450761900. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57450761900
  2. ORCID. (n.d.). Diana Hristova Research Profile.

    https://orcid.org/0000-0002-9710-1312

Georg Feigl | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Nabil Alageli | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assoc. Prof. Dr. Nabil Alageli | Clinical Medicine | Research Excellence Award

Consultant Orthopaedic Surgeon | Tripoli University Hospital | Libya

Prof. Nabil A. Alageli is a distinguished consultant orthopaedic and spine surgeon and an associate professor of surgery whose career reflects longstanding commitment to clinical excellence, academic leadership, and national health-system development. His expertise spans complex trauma, spinal injuries, degenerative spine disorders, arthroscopic procedures, and joint reconstruction, complemented by substantial experience in managing large tertiary hospitals and advancing medical training programs.His contributions to hospital governance, health-system reform initiatives, and professional societies underscore his broader societal impact, reflecting a career dedicated not only to surgical practice but also to advancing healthcare quality, institutional capacity, and community service. He has 25 citations from 3 documents with an h-index of 2.

Citation Metrics (Scopus)

25

20

15

10

5

0

Citations
25

Documents
3

h-index
2

                       🟦 Citations             🟥 Documents          🟩 h-index

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile

Featured Publications

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Emine Afşin | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID
Featured Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.